References
- Yabroff KR, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst 2007;99:14-23
- Hornbrook MC. Definition and measurement of episodes of care in clinical and economic studies. In Conference Proceedings: Cost Analysis Methodology for Clinical Practice Guidelines, edited by Grady MC, Weis KA. DHHS Pub No (PHS) 95-001. Rockville, MD: Agency for Health Care Policy and Research, 1995, pp 15-40
- Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002;40(Suppl8):IV-104-17
- Seidler AM, Pennie ML, Veledar E, et al. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare data. Arch Dermatol 2010;146:249-56
- Chang S, Long SR, Kutikova L, et al. Burden of pancreatic cancer and disease progression: economic analysis in the US. Oncology 2006;70:71-80
- Paramore LC, Thomas SK, Knopf KB, et al. Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 2006;6:52-8
- Joyce AT, Iacoviello JM, Nag S, et al. End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care 2004;27:2829-35
- Fintel D, Joyce A, Mackell J, et al. Reduced mortality rates after intensive statin therapy in managed-care patients. Value Health 2007;10:161-9
- Pelletier EM, Shim B, Goodman S, et al. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008;108:297-305
- Stafkey-Mailey D, Wang W, Murty S, Shetty S. Validation of an Algorithm to Identify Death in Administrative Claims Data. JMCP 2017;23:S38
- National Institutes of Health (NIH) National Cancer Institute. Surveillance research program: Joinpoint trend analysis software. Version 4.2.0 – April 2015; Statistical Methodology and Applications Branch. https://surveillance.cancer.gov/joinpoint/
- Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51 (correction: 2001;20:655)
- Thein HH, Isaranuwatchai W, Campitelli MA, et al. Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology 2013;58:1375-84
- Brown ML, Riley GF, Potosky AL, et al. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999;37:1249-59
- Guy GP Jr, Ekwueme DU, Tangka FK, et al. Melanoma treatment costs: a systematic review of the literature, 1990–2011. Am J Prev Med 2012;43:537-45